1. Public Law: Prescription Drug Marketing Act of 1987. Pul. L No. 100–293, 102 Stat. 95 342 (Apr. 22, 1988). Available at: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/PrescriptionDrugMarketingActof1987/ucm201702.htm . Accessed on: May 10, 2011.
2. Goldsworthy RC, Schwartz NC, Mayhorn CB. Beyond abuse and exposure: framing the impact of prescription-medication sharing. Am J Public Health. 2008; 98: 1115–1121.
3. Grzybowski S. The black market in prescription drugs. Med Crime Punishment. 2004; 364: 28–29.
4. Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010; 38(5): 517–524.
5. Forgione DA, Neuenschwander P, Vermeer TE. Diversion of prescription to the black market: what the states are doing to curb the tide. Health Care Finance. 2001; 27: 65–78.